Clements J M, Newham P, Shepherd M, Gilbert R, Dudgeon T J, Needham L A, Edwards R M, Berry L, Brass A, Humphries M J
British Bio-technology Ltd, Cowley, Oxford, UK.
J Cell Sci. 1994 Aug;107 ( Pt 8):2127-35. doi: 10.1242/jcs.107.8.2127.
The integrin adhesion receptor alpha 4 beta 1 binds two ligands, the extracellular matrix glycoprotein fibronectin and the immunoglobulin superfamily member VCAM-1. Ligand-binding sites are contained with the HepII/IIICS domain of fibronectin, and within the homologous immunoglobulin domains 1 and 4 of VCAM-1. Previous studies have shown that the binding of each ligand to alpha 4 beta 1 is mutually exclusive, suggesting that they may employ similar mechanisms to bind receptor. Fibronectin contains at least three distinct peptide sequences that are active sites for alpha 4 beta 1 binding, two homologous sequences Leu-Asp-Val-Pro (LDVP) and Ile-Asp-Ala-Pro (IDAP), and a third related to Arg-Gly-Asp (RGD). Using a combination of site-directed mutagenesis and synthetic peptide approaches in conjunction with VCAM-1-dependent cell adhesion assays, we now report the identification of a key alpha 4 beta 1-binding sequence in both domains 1 and 4 of VCAM-1 as the tetrapeptide Ile-Asp-Ser-Pro (IDSP). Mutagenesis studies also suggest that an additional sequence in domain 1, KLEK, participates in receptor binding. Since IDSP is homologous to the LDVP and IDAP fibronectin peptides, this therefore provides a molecular explanation for the promiscuity of ligand binding by alpha 4 beta 1 and has implications for the design of synthetic VCAM-1 antagonists. The extrapolation of these findings to other integrin-binding immunoglobulin ligands is also discussed.
整合素黏附受体α4β1可结合两种配体,即细胞外基质糖蛋白纤连蛋白和免疫球蛋白超家族成员血管细胞黏附分子-1(VCAM-1)。配体结合位点存在于纤连蛋白的HepII/IIICS结构域以及VCAM-1的同源免疫球蛋白结构域1和4内。先前的研究表明,每种配体与α4β1的结合是相互排斥的,这表明它们可能采用相似的机制来结合受体。纤连蛋白包含至少三个不同的肽序列,这些序列是α4β1结合的活性位点,两个同源序列亮氨酸-天冬氨酸-缬氨酸-脯氨酸(LDVP)和异亮氨酸-天冬氨酸-丙氨酸-脯氨酸(IDAP),以及第三个与精氨酸-甘氨酸-天冬氨酸(RGD)相关的序列。通过结合定点诱变和合成肽方法以及依赖VCAM-1的细胞黏附试验,我们现在报告在VCAM-1的结构域1和4中鉴定出一个关键的α4β1结合序列,即四肽异亮氨酸-天冬氨酸-丝氨酸-脯氨酸(IDSP)。诱变研究还表明,结构域1中的另一个序列KLEK参与受体结合。由于IDSP与纤连蛋白肽LDVP和IDAP同源,因此这为α4β1配体结合的混杂性提供了分子解释,并对合成VCAM-1拮抗剂的设计具有启示意义。还讨论了将这些发现外推到其他整合素结合免疫球蛋白配体的情况。